The Pressure Relieving Capacity of Siliconepads Compared to Felted Foam to Relieve Caput Metatarsal 2 in a Population With Diabetes
Siliconepads
1 other identifier
observational
80
0 countries
N/A
Brief Summary
To evaluate the clinical effectiveness of siliconepads and if they could be an alternative to felted foam used in offloading high risk pressure areas in the plantar forefoot region using plantar pressure measurements. Also user experience will be evaluated which is an important criterion in the use of this new type of offloading. Comfort, convenience and functionality of both felted foam and siliconepads will be tested to evaluate if siliconepads are more appropriate then felted foam.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedStudy Start
First participant enrolled
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2028
September 22, 2025
September 1, 2025
2.5 years
September 8, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plantar pressure reduction
Achieve a plantar pressure decrease of 25%, leading to less than 200kpa under the 2nd caput metatarsal region after wearing siliconepads in comparison to barefoot plantar pressure measurement at baseline and after 48 hours. Achieve a plantar pressure decrease of 25% or less then 200kpa in the 2nd caput metatarsal region after wearing felted foam in comparison to barefoot plantar pressure measurement at baseline and after 48 hours.
48 hours
Interventions
Plantar pressure measurement
Plantar pressure measurement
Eligibility Criteria
Diabetic patients with peripheral neuropathy
You may qualify if:
- Diabetes, Peripheral neuropathy, able to walk 5 minutes, able to sign informed consent
You may not qualify if:
- No diabetes, No neuropathy, not able to walk without walking aid, not able to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Caren Randon
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 15, 2025
Study Start
October 8, 2025
Primary Completion (Estimated)
March 30, 2028
Study Completion (Estimated)
October 30, 2028
Last Updated
September 22, 2025
Record last verified: 2025-09